Overview

Update
Status
Acquired by on July 24, 2012
Total Equity Funding
$18.42M in 3 Rounds from 3 Investors
Headquarters:
Martinsried, Bayern
Description:
Corimmun is a drug development company focused on therapeutics and diagnostics for heart and vascular diseases.
Categories:
Biotechnology, Health Diagnostics
Website:
http://www.corimmun.com

Company Details

Update

Funding Rounds (3) - $18.42M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2010€7.45M / Series B1
Sep, 2008€5M / Series A2
Jan, 2007€680k / Seed2

News (4)

Update
DateNews
Sep 27, 2016evaluategroup.com - Loading data, please wait...
Feb 19, 2014jnj.com - Janssen Acquires Corimmun
Jun 28, 2012PRNewswire All - Janssen Acquires CorImmun
Apr 30, 2010foerderland.de - Corimmun raises 879648 in seed round

Offices/Locations (1)

Update
  • Headquarters

    Lochhamer Str. 29; Rückgebäude

    Martinsried, Bayern D-82152

    Germany

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos